Cbio A
@cbio.dk
Cbio A/S is a biopharmaceutical company developing next generation T-cell therapies against solid tumors. We are soon to enter our First-in-Human clinical study at Karolinska Hospital in Sweden with our proprietary T-cell product, novoleucel, where the T-cell are armed against oxidative stress. We are located in Copenhagen, Denmark in a 1,000 m2 state-of-the-art facility where we develop and produce cell-based therapy products for clinical use.
Cbio A's Company Logos
Cbio A's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#A81F23
Roof Terracotta
168, 31, 35
358, 69, 39
0, 82, 79, 34
#EB696E
Sunglo
235, 105, 110
358, 76, 67
0, 55, 53, 8
#2A528F
St Tropaz
42, 82, 143
216, 55, 36
71, 43, 0, 44
About Cbio A
Cbio A/S is a biopharmaceutical company on a mission to cure cancer patients by providing T-cell based immunotherapies worldwide. Their focus lies in Tumor Infiltrating Lymphocyte (TIL) therapy, which shows immense promise in treating solid tumors. Cbio aims to revolutionize cancer treatment by developing next-generation cell-based immunotherapies for solid tumors, which account for 90% of all cancers.
Their groundbreaking TIL product, novoleucel, offers minimal invasiveness, a broader T-cell repertoire, shorter production time, and industrial scalability without compromising yield. Located in Søborg, Copenhagen, Cbio operates from a state-of-the-art facility with a manufacturing authorization to produce advanced therapy medicinal products for clinical use. With cleanroom facilities boasting a current capacity to treat up to 150 TIL patients annually, Cbio plans to expand to accommodate up to 600 patients per year.
Cbio collaborates with prestigious institutions such as Karolinska Institute in Stockholm and the University of Copenhagen to advance their TIL therapy to clinical testing phases. Additionally, they partner with Odense University Hospital to optimize TIL products for various cancers. Cbio's dedicated team and innovative technology position them at the forefront of cancer research and treatment.
Contact Cbio A/S at the provided address and contact info to learn more about their groundbreaking work in the fight against cancer
Company type
Privately Held
Year founded
2019
Company size
11-50 employees
